AVITA Medical annual capital expenditures (capex)
2018
2019
2020
2021
2021
2022
2023
2024
2025
AVITA Medical Capital Expenditures (CapEx) Growth & History (RCEL)
AVITA Medical's capital expenditures (capex) was $1.0M for fiscal 2025.
View full AVITA Medical company overviewAVITA Medical annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.0M | −$8.2M | −89.04% |
| 2024 | 2024-12-31 | $9.2M | $7.8M | +564.08% |
| 2023 | 2023-12-31 | $1.4M | $929,000 | +205.53% |
| 2022 | 2022-12-31 | $452,000 | $387,000 | +595.38% |
| 2021 · Dec 31 | 2021-12-31 | $65,000 | — | — |
| 2021 · Jun 30 | 2021-06-30 | $894,000 | $304,000 | +51.53% |
| 2020 | 2020-06-30 | $590,000 | −$431,000 | −42.21% |
| 2019 | 2019-06-30 | $1.0M | $656,000 | +179.73% |
| 2018 | 2018-06-30 | $365,000 | — | — |
AVITA Medical quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $108,000 | −$416,000 | −79.39% |
| Q1 2026 | 2026-03-31 | $19,000 | −$202,000 | −91.40% |
| Q4 2025 | 2025-12-31 | $674,000 | −$938,000 | −58.19% |
| Q3 2025 | 2025-09-30 | $934,000 | −$2.8M | −75.16% |
| Q2 2025 | 2025-06-30 | $524,000 | −$2.1M | −80.24% |
| Q1 2025 | 2025-03-31 | $221,000 | −$926,000 | −80.73% |
| Q4 2024 | 2024-12-31 | $1.6M | $1.3M | +444.59% |
| Q3 2024 | 2024-09-30 | $3.8M | $3.3M | +649.00% |
| Q2 2024 | 2024-06-30 | $2.7M | $2.4M | +786.96% |
| Q1 2024 | 2024-03-31 | $1.1M | $863,000 | +303.87% |
| Q4 2023 | 2023-12-31 | $296,000 | $226,000 | +322.86% |
| Q3 2023 | 2023-09-30 | $502,000 | $398,000 | +382.69% |
| Q2 2023 | 2023-06-30 | $299,000 | $85,000 | +39.72% |
| Q1 2023 | 2023-03-31 | $284,000 | $220,000 | +343.75% |
| Q4 2022 | 2022-12-31 | $70,000 | −$354,000 | −83.49% |
| Q3 2022 | 2022-09-30 | $104,000 | $37,000 | +55.22% |
| Q2 2022 | 2022-06-30 | $214,000 | $118,000 | +122.92% |
| Q1 2022 · Mar 31 | 2022-03-31 | $64,000 | −$262,000 | −80.37% |
| Q4 2021 | 2021-12-31 | $424,000 | $161,000 | +61.22% |
| Q1 2022 · Sep 30 | 2021-09-30 | $67,000 | −$142,000 | −67.94% |
| Q4 2021 | 2021-06-30 | $96,000 | −$30,000 | −23.81% |
| Q3 2021 | 2021-03-31 | $326,000 | −$10,000 | −2.98% |
| Q2 2021 | 2020-12-31 | $263,000 | $221,000 | +526.19% |
| Q1 2021 | 2020-09-30 | $209,000 | $123,000 | +143.02% |
| Q4 2020 | 2020-06-30 | $126,000 | — | — |
| Q3 2020 | 2020-03-31 | $336,000 | — | — |
| Q2 2020 | 2019-12-31 | $42,000 | — | — |
| Q1 2020 | 2019-09-30 | $86,000 | — | — |
AVITA Medical capital expenditures (capex) trends
Between the periods ended 2018-06-30 and 2025-12-31, AVITA Medical's capital expenditures (capex) increased from $365,000 to $1.0M, a change of $640,000. The latest reported quarter, Q2 2026, shows $108,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AVITA Medical source filings ↗